Call Us: +44 (0) 1752 753723[email protected]

Caroline Wyatt: MS ‘brain fog’ lifted after stem cell treatment

BBC journalist Caroline Wyatt has spoken of how the “brain fog began to lift” after she had pioneering treatment for multiple sclerosis (MS).   The former BBC defence correspondent was deemed unsuitable for an NHS trial and paid $60,000 (£48,000) for a stem cell transplant in Mexico in January....

Stunning results with Hadassah’s stem cell treatment

The Hadassah Medical Center is continuing to receive positive findings with its Phase II clinical trial using its unique stem cell approach to stop the progression and reversing the disabilities of multiple sclerosis. The Hadassah-developed treatment involves intrathecal injection-injection of the patient’s own bone marrow-derived stem cells directly into...

Stem cell transplant gives Ottawa area woman new lease on life

A stem cell transplant has given a Kemptville woman a new lease on life, after being on life support twelve times. The man behind it all is Dr. Harold Atkins, the very same doctor who has been using stem cell transplants here in Ottawa to treat people with Multiple...

Stem cell treatment shows signs of hope for boy

Three-year old James Habeck and his family have returned from a medical trip to Panama. His mother Melissa Habeck said they are noticing signs of improvement as a result of the stem cell treatment James received at the Stem Cell Institute in Panama City, Panama. Treatment is hoped to...

Common athlete’s foot cream ‘could reverse multiple sclerosis’

US researchers found that the drug miconazole instructs stem cells in the brain to repair the nerve damage of MS. A common athlete’s foot cream sold over the counter at most chemists could cure multiple sclerosis, scientists believe. In what was described as a ‘paradigm shift’ in treating the...

Stem Cells Used to Treat Secondary Progressive Patients with MS in Clinical Trial

A phase 2 clinical study from an international group of research centers compared head-to-head autologous hematopoietic stem cell transplantation (AHSCT) and mitoxantrone in treating patients with secondary progressive or relapsing-remitting multiple sclerosis. The findings showed that MRI-detected brain lesions were reduced by 79% in patients undergoing AHSCT compared to...

Stem Cell Therapy Shows Promise for MS Patients

A preliminary Northwestern Medicine study suggests that nonmyeloablative hematopoietic stem cell transplantation may reverse disability and improve quality of life for patients with relapsing-remitting multiple sclerosis (MS). MS is an immune-mediated disorder of the central nervous system often arising in young adulthood. It damages the nerve cells in the...

Stem Cell Transplants Offer First-Ever MS Treatment That Reverses Disability

Only 2 years after getting a stem cell transplant, half of volunteers showed improvement in their disability scores — a first for any MS therapy. Dr. Richard K. Burt performed the first hematopoietic stem cell transplant (HSCT) for a multiple sclerosis (MS) patient in the United States at Chicago’s...

Update on MS patients – 3 years after stem cell transplant

Three years after a small number of patients with multiple sclerosis (MS) were treated with high-dose immunosuppressive therapy (HDIT) and then transplanted with their own hematopoietic stem cells, most of the patients sustained remission of active relapsing-remitting MS (RRMS) and had improvements in neurological function, according to a study...